MANE:NYSE
Veradermics Inc
$110.41
arrow_upward
+1.33%(+1.45) 1D
Oct 7, 2:12:33 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANE...
Open
$108.92
High
$113.42
Low
$108.84
Mkt. cap
4.61B
Avg. vol.
700.67K
Volume
372.85K
52-wk high
$131.24
52-wk low
$32.00
EPS
-$3.35
No. of employees
37
Open
$108.92
High
$113.42
Low
$108.84
Mkt. cap
4.61B
Avg. vol.
700.67K
Volume
372.85K
52-wk high
$131.24
52-wk low
$32.00
EPS
-$3.35
No. of employees
37
News stories
From web sources and news partners
MarketBeat
·
20 minutes ago
Veradermics (NYSE:MANE) Stock Jumps 3.4% - Time to Buy?
About Veradermics Inc
CEO-
Employees37
Founded2019
HeadquartersNew Haven, Connecticut, United States
SectorPharmaceutical industry
Websiteveradermics.com
Analyst ratings
Based on 5 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current $110.41
$182.00 (+64.84%)
Average
$169.20 (+53.25%)
Lowest
$160.00 (+44.91%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Geoff Meacham Citi | Buy | Maintained | $160.00 | +44.9% | 09/15/2026 |
Roger Song Jefferies | Buy | Maintained | $182.00 | +64.8% | 09/08/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $182.00 | +64.8% | 09/08/2026 |
Serge Belanger Needham | Buy | Maintained | $164.00 | +48.5% | 08/12/2026 |
Rami Katkhuda LifeSci Capital | Buy | Maintained | $170.00 | +54% | 08/11/2026 |
Mayank Mamtani B. Riley Securities | Buy | Initiated | $170.00 | +54% | 07/15/2026 |
Marc Goodman Leerink Partners | Buy | Initiated | $75.00 | -32.1% | 03/02/2026 |
Prakhar Agrawal Cantor Fitzgerald | Buy | Initiated | - | - | 03/01/2026 |
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.58 / -$0.64
+9.56%beat
arrow_upward
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | - | - | - | - |
Cost of goods sold | - | - | - | - |
Cost of revenue | - | - | - | - |
Research and development expenses | 14.33M | 18.19M | 20.92M | 18.61M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.74M | 4.82M | 8.94M | 10.95M |
Operating expense | 16.07M | 23.01M | 29.86M | 29.55M |
Total operating expenses | 16.07M | 23.01M | 29.86M | 29.55M |
Operating income | -16.07M | -23.01M | -29.86M | -29.55M |
Other non operating income | 325.00K | 258.00K | 149.00K | 1.21M |
EBT including unusual items | -15.64M | -21.85M | -27.23M | -23.50M |
EBT excluding unusual items | -15.64M | -21.85M | -27.23M | -23.50M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -15.64M | -21.85M | -27.23M | -23.50M |
Net profit margin | - | - | - | - |
Earnings per share | - | -104.54 | -1.32 | -0.58 |
Interest and investment income | 103.00K | 906.00K | 2.48M | 4.84M |
Interest expense | - | - | - | - |
Net interest expenses | 103.00K | 906.00K | 2.48M | 4.84M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | - | - | - | - |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1